No profile data available.
DaVita Inc. (DVA) is a healthcare company in the focused walk-in medical services industry, based in Denver, United States, with about 78,000 full-time employees.
It reported revenue of $13.64 billion for fiscal year 2025, up 6.5% from fiscal year 2024, and net income of $746.80 million. Its largest business segment, U.S. Dialysis, brought in 86% of segment revenue in fiscal year 2025. Its market capitalization was $11.51 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers.
DaVita reported $13.64 billion in revenue for fiscal year 2025, up 6.5% from $12.82 billion in fiscal year 2024.
U.S. Dialysis, with $11.79 billion or 86% of segment revenue in fiscal year 2025. Next: Other - Ancillary Services - International (10%) and Other - Ancillary Services - U.S. Integrated Kidney Care (4%).
$11.51 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (focused walk-in medical services) include Fresenius Medical Care AG (FMS), American Oncology Network, Inc. (AONC), The Oncology Institute, Inc. (TOI), The Joint Corp. (JYNT).